The role of nitro-reduction and nitric oxide in the toxicity of chloramphenicol

Human and Experimental Toxicology

Volumn 18, Issue 2, 1999, Pages 111-118

  Holt, Daphne E ^a   Bajoria, Rekha ^b  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; Chloramphenicol; Nitric oxide; Nitro reduction

Indexed keywords

CHLORAMPHENICOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD TOXICITY; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTENSION; NEWBORN; PLACENTA; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; ANTIPYRINE; BLOOD VESSELS; CHLORAMPHENICOL; DRUG INTERACTIONS; FEMALE; HUMANS; INFANT, NEWBORN; LIVER; NITRIC OXIDE; OXIDATION-REDUCTION; PERFUSION; PLACENTAL CIRCULATION; PREGNANCY;

EID: 0033059488     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032799678839770     Document Type: Article

References (34)

1. Holt DE et al. The myelotoxicity of chloramphenicol: in vitro and in vivo studies: I. In vitro effects on cells in culture. Human & Experimental Toxicology 1997; 16: 570-576.
2. Holt DE at al. The myelotoxicity of chloramphenicol: in vitro and in vivo studies: II. In vivo myelotoxicity in the B6C3F, mouse. Human & Experimental Toxicology 1998; 17: 8-17.
3. Bonfoco E et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with n-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proceedings National Academy of Science USA 1995; 92: 7162-7166.
4. Salem Z, Murray T, Yunis AA. The nitroreduction of chloramphenicol by human liver tissue. Journal Laboratory Clinical Medicine 1981; 97; 881-886.
5. Holt DE, Harvey D, Hurley R. Chloramphenicol toxicity. Adverse Drug Reactions & Toxicological Reviews 1993; 12: 83-95.
6. Isildar M et al. Aerobic nitroreduction of dehydrochloramphenicol by bone marrow. Toxicology & Applied Pharmacology 1988; 94: 305-310.
7. Eyer P, Lierheimer E, Schneller M. Reactions of nitroso-chloramphenicol in blood. Biochemical pharmacology 1984; 33: 2299-2308.
8. Holt DE, Harvey D, Hurley R. A reappraisal of chloramphenicol metabolism: detection and quantification of metabolites in the sera of children. Journal of Antimicrobial Chemotherapy 1995; 35: 115-127.
9. Holt DE. The biotransformation of chloramphenicol: metabolic pathways in the very young child. PhD Thesis, 1992, University of London.
10. Ambrose PJ. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. Clinical Pharmacology 1984; 9: 222-238.
11. Craft AW, Brocklebank JT, Hey EN, Jackson RH. The 'grey toddler'. Chloramphenicol toxicity. Archives of Disease in Childhood 1974; 49: 235-237.
12. Thompson WL, Anderson SE, Lipsky JJ. Overdoses of chloramphonicol. Journal of the American Medical Association 1975; 234: 149-150.
13. Mullhall A, de Louvois J, Hurley R. The pharmacokinetics of chloramphenicol in the neonate and young infant. Journal of Antimicrobial Chemotherapy 1983; 12: 629-639.
14. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochemical & Biophysical Research Communications 1990; 172: 1132-1138.
15. Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. American Journal of Obstetrics & Gynaecology 1992; 166: 224-230.
16. Hull AD, White CR, Pearce WJ. Endothelium-derived relaxing factor and cyclic GMP dependent vasorelaxation in human chorionic: plate arteries. Placenta 1994; 15: 365-376.
17. Ramsey B et al. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. European Journal of Clinical Investigation 1994; 24: 76-78.
18. Holt DE, Harvey D, Hurley R. The metabolism of chloramphenicol by glutathione S-transferase in human fetal and neonatal liver. Biology of the Neonate 1995; 67: 230-239.
19. Bratton AC, Marshall EK. A new coupling component for sulfanilamide determination. Journal of Biological Chemistry 1939; 128: 537-550.
20. Ascherl M, Eyer P, Kampffmeyer H. Formation and disposition of nitrosochloramphenicol in rat liver. Biochemical Pharmacology 1985; 34: 3755-3763.
21. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. American Journal of Obstetrics & Gynaecology 1972; 144: 822-828.
22. Brodie BB, Axelrod J, Soberman R, Levy BB. The estimation of antipyrine in biological materials. Journal of Biological Chemistry 1949; 179: 25-31.
23. Abou-Khalil S, Abou-Khalil WH. Yunis AA. Identification of a mitochondrial p-dinitrobenzene reductase activity in rat liver. Pharmacology 1985; 31: 301-308.
24. Köchli HW, Wermuth B, von Wartburg JP. Characterization of a mitochondrial NADH-dependont nitro-reductase from rat brain. Biochimica Biophyica Acta 1980; 616: 133-142.
25. Moreno SNJ, Mason RP, Docamp R. Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase. Journal of Biological Chemistry 1984; 259: 6298-6305.
26. Freeman KB, Patel H, Halder D. Inhibition of DNA synthesis in Ehrlich ascites cells by chloramphenicol. Molecular Pharmacology 1977; 13: 504-511.
27. Miller MJS et al. Amelioration of chronic ileitis by NOS inhibition. Journal of Pharmacology and Experimental Therapeutics 1993; 264: 11-16.
28. Spain JC, Wyss O. Gibson DT. Enzymic oxidation of p-nitrophenol. Biochemical and Biophysical Research Communications 1978; 88: 634-641.
29. Zeyer J, Kearney PC. Degradation of o-nitrophenol and in-nitrophenol by Pseudomonas putida. Journal of Agricultural and Food Chemistry 1984; 32: 238-242.
30. Bruhn C, Lenke H, Knackmuss H-J. Nitrosubstituted aromatic: compounds as nitrogen source for bacteria. Applied and Environmental Microbiology 1987; 53: 208-210.
31. Needleman P. In Organic Nitrates. Needleman P (ed) 1975 pp. 57-95. Berlin. Springer-Verlag.
32. Groenewegen PEJ et al. Novel degradative pathway of 4-nitrobenzoate in Comomonas acidovorans NBA-10. Journal of General Microbiology 1992; 138: 1599-1605.
33. Groenewegen PEJ, de Bont JAM. Degradation of 4-nitrobenzoate via 4-hydroxylaminobenzoate and 3,4-dihydroxybenzoate in Comomonas acidovorans NBA-10. Archives of Microbiology 1992; 158; 381-386.
34. Mason RP, Holtzman JL. The mechanism of microsomal and mitochondrial nitroreductase. Electron spin resonance evidence for nitroaromatic free radical intermediates. Biochemistry 1975; 14: 1626-1632.